Collecting Medical Information and Tissue Samples from Patients with Pancreatic Cancer or Other Pancreatic Disorders

  • Study type:

    Observational What is this?

    Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.

Study IDs

  • Site IRB:

    • Scottsdale/Phoenix, Arizona: 354-06
    • Jacksonville, Florida: 354-06
    • Rochester, Minnesota: 354-06
  • NCT ID:

    NCT00830557
  • Sponsor Protocol Number:

    354-06

About this study

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.

PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Disease Characteristics:

  • Diagnosis or suspicion of at least one of the following:
    • Pancreatic cancer
    • Pancreatic mass
    • Islet cell tumor
    • Intraductal papillary mucinous neoplasms (IPMN)
    • Hereditary pancreatitis

Patient Characteristics:

  • Able to understand and read English
  • Mentally competent and able to provide informed consent
  • Has not donated blood within the past 8 weeks

Prior Concurrent Therapy:

  • At least 7 days since prior blood transfusion
  • At least 7 days since prior surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Gloria Petersen, Ph.D.

Contact us for the latest status

Narcelle Jean-Louis

(480)301-4714

JeanLouis.Narcelle@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Gloria Petersen, Ph.D.

Contact us for the latest status

Joy Hardee CCRP

(904)953-8456

hardee.darla@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Gloria Petersen, Ph.D.

Contact us for the latest status

Bridget Eversman

(507)266-3294

Eversman.Bridget@mayo.edu